6H3K
Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enables the discovery of the Phase 1 clinical candidate BOS172722.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04-1 |
Synchrotron site | Diamond |
Beamline | I04-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2015-08-07 |
Detector | DECTRIS PILATUS 2M |
Wavelength(s) | 0.9282 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 71.624, 107.644, 114.683 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 41.330 - 2.480 |
R-factor | 0.209 |
Rwork | 0.208 |
R-free | 0.23100 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.009 |
RMSD bond angle | 1.010 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER (2.5.7) |
Refinement software | BUSTER |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 60.520 | 60.520 | 2.740 |
High resolution limit [Å] | 2.670 | 11.940 | 2.670 |
Rmerge | 0.092 | 0.039 | 1.780 |
Rmeas | 0.101 | 0.043 | 1.936 |
Rpim | 0.039 | 0.017 | 0.755 |
Total number of observations | 83046 | 927 | 6094 |
Number of reflections | 12793 | 170 | 941 |
<I/σ(I)> | 11.7 | 38.1 | 1 |
Completeness [%] | 99.7 | 98.5 | 99.7 |
Redundancy | 6.5 | 5.5 | 6.5 |
CC(1/2) | 0.998 | 0.998 | 0.622 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 291.15 | 0.1 M Bis-Tris propane; 0.1 M MgCl2 0.1 M Sodium formate 18-26% PEG3350 |